Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nkarta, Inc. before investing.

In this article, we go over a few key elements for understanding Nkarta, Inc.’s stock price such as:

• Nkarta, Inc.’s current stock price and volume
• Why Nkarta, Inc.’s stock price changed recently
• Upgrades and downgrades for NKTX from analysts
• NKTX’s stock price momentum as measured by its relative strength

About Nkarta, Inc. (NKTX)

Before we jump into Nkarta, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Want to learn more about Nkarta, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Nkarta, Inc..

Nkarta, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Nkarta, Inc.’s stock price was $2.090.

Nkarta, Inc. is down 2.79% from its previous closing price of $2.150.

During the last market session, Nkarta, Inc.’s stock traded between $2.045 and $2.180. Currently, there are approximately 74.26 million shares outstanding for Nkarta, Inc..

Nkarta, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Nkarta, Inc. Stock Price History

Nkarta, Inc.’s (NKTX) price is currently down 26.15% so far this month.

During the month of July, Nkarta, Inc.’s stock price has reached a high of $3.720 and a low of $2.045.

Over the last year, Nkarta, Inc. has hit prices as high as $3.720 and as low as $1.700. Year to date, Nkarta, Inc.’s stock is up 12.97%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Nkarta, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 2 analysts who downgraded Nkarta, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Nkarta, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Nkarta, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Nkarta, Inc. (NKTX) by visiting AAII Stock Evaluator.

Relative Price Strength of Nkarta, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Nkarta, Inc. has a weighted four-quarter relative price strength of -8.31%, which translates to a Momentum Score of 28 and is considered to be Weak.

Want to learn more about how Nkarta, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Nkarta, Inc. Stock Price: Bottom Line

As of July 31, 2026, Nkarta, Inc.’s stock price is $2.090, which is down 2.79% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Nkarta, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.